OakChart

Universal Health Realty Income Trust

UHTReal Estate·REIT - Healthcare Facilities·USA·Small·NYSE·Nov 11 • 10:54 AM ET

38.49-0.27 (-0.71%)
2026-11-11 16:55 CET
Market cap
538.75 USD m
Revenue, TTM
99.34 USD m
Net income, TTM
20.18 USD m
Free cash flow, TTM
47.83 USD m
EPS diluted, TTM
1.45
P/E
26.48
Compare

Price

UHT against its 20, 50 and 200-day averages
2050200earnings
37.5040.0042.5045.001.2M2.3MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26UHTclose 38.4920-day 38.0750-day 38.65200-day 41.0738.4952w high52w low

16.9% under the 52-week high of 46.30 on 2 Jul 2026. 52-week low 36.07 on 1 Oct 2026. Last 15 sessions, 9.6% high to low

Profile

UHT
52-week range, 24% of the way up
36.0746.30

Universal Health Realty Income Trust operates as a real estate investment trust. It engages in investing and leasing healthcare and human service facilities through direct ownership or joint ventures. The firm focuses on investing in acute care hospitals, behavioral health care hospitals, free-standing emergency departments, childcare centers, and medical or office buildings. The company was founded on December 24, 1986 and is headquartered in King of Prussia, PA.

IndexRUT
IPODec 26, 1986
Beta0.84
ATR, 14d1.02
Rel volume0.28
Short float2.20%
Insider own8.42%
Inst own61.83%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap534.93M
Enterprise Value935.56M
Income20.18M
Sales99.34M
Book/sh10.04
Cash/sh0.47
Dividend Est.-
Dividend TTM2.99 (7.77%)
Dividend Ex-DateSep 21, 2026
Dividend Gr. 3/5Y1.39% 1.41%
Payout233.05%
Employees-
IPODec 26, 1986

Ratios

P/E26.48
Forward P/E-
PEG-
P/S5.38
P/B3.83
P/C82.68
P/FCF11.18
EV/EBITDA14.18
EV/Sales9.42
Quick Ratio7.88
Current Ratio7.88
Debt/Eq2.92
LT Debt/Eq2.92
Option/ShortYes / Yes

Earnings

EPS (ttm)1.45
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y-6.01% -2.11%
Sales past 3/5Y3.06% 4.92%
EPS Y/Y TTM12.24%
Sales Y/Y TTM-0.02%
EPS Q/Q22.49%
Sales Q/Q0.17%
EarningsOct 27 AMC
EPS/Sales Surpr.- 1.79%

Ownership

Insider Own8.42%
Insider Trans0.00%
Inst Own61.83%
Inst Trans-0.65%
ROA3.54%
ROE13.54%
ROIC3.69%
Gross Margin35.85%
Oper. Margin38.07%
Profit Margin20.31%
SMA201.08%
SMA50-0.42%
SMA200-6.29%
Trades-

Technical

Shs Outstand13.90M
Shs Float12.73M
Short Float2.20%
Short Ratio2.24
Short Interest0.28M
52W High46.30 -16.88%
52W Low36.07 6.70%
Volatility2.41% 2.64%
ATR (14)1.02
RSI (14)50.90
Beta0.84
Rel Volume0.28
Avg Volume124.95K
Volume9,063

Performance

Perf Week-2.17%
Perf Month1.79%
Perf Quarter-6.73%
Perf Half Y-4.15%
Perf YTD-1.85%
Perf Year-2.67%
Perf 3Y-1.62%
Perf 5Y-35.80%
Perf 10Y-30.28%
Recom1.00
Target Price40.00
Prev Close38.76
Price38.49
Change %-0.71%

Analyst ratings

latest 2 of 2
DateActionAnalystRating changeTargetImplied
Apr 21, 2010DowngradeJJefferiesBuy → Hold$40 → $34-11.7%
Jan 13, 2010InitiatedJJefferies & CoBuy$40+3.9%

Peers

Mkt cap
TickerCompanyMkt cap
CHCTCommunity Healthcare Trust Inc425.63M
XRNChiron Real Estate Inc385.92M
MPTMedical Properties Trust Inc1.07B
HRHealthcare Realty Trust Inc6.48B
DOCHealthpeak Properties Inc14.30B
NHPNational Healthcare Properties Inc1.12B
DHCDiversified Healthcare Trust1.79B
AHRAmerican Healthcare REIT Inc13.86B
VTRVentas Inc48.81B
WELLWelltower Inc180.10B

Held by

AUM
TickerCompanyAUM
VNQVanguard Real Estate Index Fund ETFAUM: 38.99B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
DIVGlobal X SuperDividend U.S. ETFAUM: 773.37M
IWMiShares Russell 2000 Index FundAUM: 77.38B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
DFARDFA Real Estate Securities Portfolio ETF Class Shares-
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
USRTiShares Core U.S. REIT ETFAUM: 4.30B

News

latest 14 of 206
  • Universal Health Realty: Q3 Earnings Snapshot (Associated Press)
  • Universal Health Realty Holds FFO Flat At $0.88 As A GAAP Lift Masks A Stalled Core And Tenant UHS Flags Palm Beach Gardens Strain (Earnings Whispers)
  • UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2026 (PR Newswire)
  • Universal Health Realty Income Trust's Dividend Analysis (GuruFocus.com)
  • UNIVERSAL HEALTH REALTY INCOME TRUST ANNOUNCES DIVIDEND (PR Newswire)
  • Loading…
  • Universal Health Realty: Q2 Earnings Snapshot (Associated Press)
  • UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS FINANCIAL RESULTS FOR THE THREE AND SIX-MONTH PERIODS ENDED JUNE 30, 2026 (PR Newswire)
  • UNIVERSAL HEALTH REALTY INCOME TRUST ANNOUNCES DIVIDEND INCREASE (PR Newswire)
  • Marvell Technology and Flex Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 (PR Newswire) -5.05%
  • Universal Health Realty: Q1 Earnings Snapshot (Associated Press)
  • UNIVERSAL HEALTH REALTY INCOME TRUST REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS (PR Newswire)
  • UNIVERSAL HEALTH REALTY INCOME TRUST ANNOUNCES DIVIDEND (PR Newswire)
  • Universal Health Realty Stock Gains Post Q4 Earnings, Revenue Slips (Zacks)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-270.350--25.3524.90-
2026Q22026-07-270.430-0.42624.9924.70-
2026Q12026-04-270.360-0.36224.5324.70-
2025Q42026-02-250.310-0.31224.4725.30-
2025Q32025-10-270.290-0.29025.3024.90-
2025Q22025-07-280.320-0.32424.87--
2025Q12025-04-28--0.345---
2024Q42025-02-26--0.337---
2024Q32024-10-24--0.289---
2024Q22024-07-240.380-0.38124.73--
2024Q12024-04-24--0.383---
2023Q42024-02-270.280-0.260---
2023Q32023-10-25--0.280---
2023Q22023-07-25--0.252---
2023Q12023-04-250.320-0.323---
2022Q42023-02-27--0.408---

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2010FY1.3302.6271.33028.8829.67
2012FY0.920-1.54053.95-
2013FY1.060-1.04054.28-
2024FY1.390-1.39099.01-
2025FY1.270--99.19100
2026FY-1.730--100.2
2027FY-1.820--101.6
2028FY-1.910--112.83
2029FY-2.010--115.72

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-2811025.5025.5025.50
2026Q4S2026-10-2710025.1025.1025.10
2026Q4S2026-07-2810025.1025.1025.10
2026Q4S2026-04-3010025.0025.0025.00
2026Q4S2026-04-2810025.2025.2025.20
2026Q4S2026-03-3110025.2025.2025.20
2026Q3S2026-07-2810024.9024.9024.90
2026Q3S2026-07-2710024.9024.9024.90
2026Q3S2026-06-0310024.9024.9024.90
2026Q3S2026-04-3010124.9024.9024.90
2026Q3S2026-04-2810125.0025.0025.00
2026Q3S2026-03-3110125.0025.0025.00
2026Q3S2025-11-1110025.5025.5025.50
2026Q2S2026-06-0310024.7024.7024.70

Estimate history

EPS, annual3.351.7631.3791.4137.9231.531.1151.391.271.4536
Period201720182019202020212022202320242025TTM
EPS, quarterly0.2890.3370.3450.3240.290.3120.3620.4260.355
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual72.34876.2177.16378.0184.1990.62595.57599.01199.1999.34
Period201720182019202020212022202320242025TTM
Sales, quarterly24.49424.64224.54824.86825.30224.47224.52924.99125.346
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual13.73513.74713.75713.77113.78513.80313.82413.85113.87513.9
Period201720182019202020212022202320242025MRQ
Shares, quarterly13.84913.85113.85113.87413.87413.87513.87613.89913.9
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue99.3499.1999.0195.5890.6284.1978.0177.1676.21
Total Expenses61.5259.9056.4657.2958.9456.5652.6951.4149.51
Operating Income37.8139.2942.5538.2931.6927.6325.3225.7526.70
Unusual Expense0.000.000.000.000.000.000.000.00-5.70
Net Income Before Taxes20.1817.6119.2315.4021.10109.1719.0518.9624.20
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income20.1817.6119.2315.4021.10109.1719.0518.9624.20
Net Income From Continuing Operations20.1817.6119.2315.4021.10109.1719.0518.9624.20
Net Income20.1817.6119.2315.4021.10109.1719.0518.9624.20
EPS (Recurring)1.451.271.391.111.537.921.411.381.47
EPS (Basic, Before Extraordinaries)1.461.271.391.121.537.941.421.381.76
EPS (Diluted)1.451.271.391.111.537.921.411.381.76
Non-Operating Income (Expense)2.640.201.28-0.121.1989.111.713.751.77
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.890.940.850.780.780.950.910.700.57
Price To Earnings Ratio26.6626.6628.3334.256.147.5145.4985.1134.87
Price To Sales Ratio5.235.485.206.257.279.7311.3420.9211.05
Gross Margin35.8536.5637.1633.9533.8434.2933.3333.3735.04
Operating Margin38.0739.6142.9840.0634.9632.8232.4633.3735.04
Net Margin20.3117.7519.4316.1123.28129.6724.4224.5831.75
Shares Outstanding13.9013.8713.8513.8213.8013.7913.7713.7613.75
Market Capitalization538.75538.75515.34597.85658.78819.76885.031,614.52843.59

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue25.3524.9924.5324.4725.3024.8724.5524.64
Total Expenses15.8615.2915.0615.3116.1115.2414.744.82
Operating Income9.489.709.479.169.199.629.8119.82
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes4.935.915.024.324.024.494.784.66
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income4.935.915.024.324.024.494.784.66
Net Income From Continuing Operations4.935.915.024.324.024.494.784.66
Net Income4.935.915.024.324.024.494.784.66
EPS (Recurring)0.350.430.360.310.290.320.340.34
EPS (Basic, Before Extraordinaries)0.360.430.360.310.290.330.350.34
EPS (Diluted)0.350.430.360.310.290.320.340.34
Non-Operating Income (Expense)0.501.150.510.480.440.360.410.32
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.220.200.190.270.240.210.210.22
Price To Earnings Ratio26.6634.0831.8630.2830.2729.5829.4728.33
Price To Sales Ratio5.236.135.665.485.475.625.765.21
Gross Margin35.3536.8336.5234.7033.1835.5636.8037.57
Operating Margin37.4138.8238.5937.4536.3338.7039.9580.44
Net Margin19.4523.6420.4617.6715.8718.0619.4618.91
Shares Outstanding13.9013.9013.8813.8713.8713.8713.8513.85
Market Capitalization538.75608.58561.51543.98543.45553.64567.32515.34

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments6.697.108.217.6122.505.746.115.043.39
Short Term Receivables97.7197.9097.6297.4494.1910.7010.6010.219.10
Investments354.74375.46394.23404.57384.35388.64377.62384.33393.25
Investment in Unconsolidated Affiliates20.1213.959.109.280.000.006.925.024.67
Net Property, Plant & Equipment11.3910.9210.9511.4611.498.918.940.000.00
Other Intangible Assets74.2575.5376.2677.1975.7475.7378.6079.1679.59
Total Assets564.91580.86596.37607.54598.42494.01488.79483.76490.01
Total Debt386.03379.17370.41354.28340.26304.01282.64261.28256.41
Long Term Debt384.71378.23358.11343.84328.06301.93280.73261.28233.06
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities26.4922.1525.0324.1622.8331.0024.4223.8623.04
Total Liabilities412.52401.32395.44378.44363.09335.00307.06285.15279.45
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity152.38179.54200.93229.10235.33159.00181.73198.61210.56
Total Shareholders Equity152.38179.54200.93229.10235.33159.00181.73198.61210.56
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity152.38179.54200.93229.10235.33159.00181.73198.61210.56
Total Liabilities & Stockholders Equity564.91580.86596.37607.54598.42494.01488.79483.76490.01
Book Value Per Share10.9812.9614.5416.6017.0711.5513.2114.4515.33
Tangible Book Value Per Share10.5812.4313.8815.9116.3510.6912.1513.1813.83
Price to Book Ratio3.862.842.842.823.485.578.884.254.84
Return on Assets3.073.272.563.5019.993.883.904.978.99
Return on Equity10.6110.117.169.0955.3711.189.9711.8322.71
Return on Invested Capital3.283.452.753.6819.384.134.105.2610.28
Quick Ratio7.858.304.444.835.101.241.241.260.37
Current Ratio7.858.304.444.835.101.241.241.260.37

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Funds from Operations49.9348.6546.8145.2349.8149.4152.5243.6244.11
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-2.101.09-1.19-1.75-2.15-3.11-2.25-0.68-2.02
Cash from Operating Activities47.8349.7445.6243.4747.6546.3050.2742.9442.09
Capital Expenditures0.000.000.000.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.00-7.62-14.97-18.92-2.27-5.11-4.05
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments-26.96-15.64-14.96-12.25-22.58-6.25-31.47-11.69-9.08
Purchase of Investments-27.71-15.64-14.96-19.64-22.58-34.37-31.47-14.45-9.08
Sale Or Maturity of Investments0.750.000.007.390.0028.120.002.770.00
Other Uses0.000.000.000.000.00-0.200.000.00-0.19
Other Sources0.000.000.000.000.000.530.000.004.54
Cash from Investing Activities-26.96-15.64-14.96-19.87-37.55-24.84-33.73-16.79-8.79
Cash Dividends Paid-41.53-41.03-40.39-39.77-39.18-38.53-37.97-37.41-36.83
Change in Capital Stock0.160.16-0.130.150.180.21-0.27-0.010.23
Repurchase of Common Pref Stock0.000.00-0.130.000.000.00-0.27-0.220.00
Sale of Common Pref Stock0.160.160.000.150.180.210.000.210.23
Proceedsfrom Stock Options0.160.160.000.150.180.210.000.210.23
Issuance or Reduction of Debt, Net-0.596.368.7516.6114.0033.6221.3412.354.95
Change in Long Term Debt-0.59-0.94-13.55-11.89-12.20-2.08-1.91-4.20-10.40
Issuance of Long Term Debt0.000.000.000.000.000.000.000.0013.00
Reduction of Long Term Debt-0.59-0.94-13.55-11.89-12.20-2.08-1.91-4.20-23.40
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities-21.31-34.51-31.77-23.01-25.00-4.70-16.90-25.07-31.65
Net Change in Cash-0.45-0.41-1.110.60-14.8916.76-0.371.071.65
Free Cash Flow47.8349.7445.6243.4747.6546.3050.2742.9442.09
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow82.4462.4098.46161.0877.67105.4871.96292.17160.10

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments6.476.827.066.696.926.55
Short Term Receivables97.7997.2197.4097.7198.0297.81
Investments363.88359.90354.35354.74356.81363.19
Investment in Unconsolidated Affiliates19.6620.0220.3620.1220.8220.95
Net Property, Plant & Equipment11.3711.3811.3911.3910.9010.90
Other Intangible Assets73.8471.8073.2074.2574.5873.62
Total Assets573.01567.12563.76564.91568.04573.02
Total Debt407.10395.10389.19386.03386.52384.42
Long Term Debt406.95394.80388.74384.71386.38384.13
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities26.4128.1126.7726.4922.9423.45
Total Liabilities433.51423.21415.96412.52409.46407.86
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity139.50143.91147.80152.38158.57165.15
Total Shareholders Equity139.50143.91147.80152.38158.57165.15
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity139.50143.91147.80152.38158.57165.15
Total Liabilities & Stockholders Equity573.01567.12563.76564.91568.04573.02
Book Value Per Share10.0410.3510.6510.9811.4311.90
Tangible Book Value Per Share9.7110.0010.2710.5810.9911.44
Price to Book Ratio3.864.123.683.433.293.22
Return on Assets3.543.383.143.073.113.09
Return on Equity13.5412.4711.1610.6110.5510.08
Return on Invested Capital0.901.100.940.810.740.82
Quick Ratio7.887.827.817.858.858.46
Current Ratio7.887.827.817.858.858.46

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Funds from Operations12.7212.6812.3112.2112.4412.01
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-3.29-0.17-0.361.73-2.101.84
Cash from Operating Activities9.4312.5111.9513.9410.3413.85
Capital Expenditures0.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-11.49-8.11-4.46-2.90-1.89-8.95
Purchase of Investments-11.49-8.86-4.46-2.90-1.89-8.95
Sale Or Maturity of Investments0.000.750.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-11.49-8.11-4.46-2.90-1.89-8.95
Cash Dividends Paid-10.39-10.52-10.30-10.31-10.23-10.33
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.10-0.020.040.040.040.04
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.10-0.020.040.040.040.04
Proceedsfrom Stock Options0.10-0.020.040.040.040.04
Issuance or Reduction of Debt, Net12.005.903.15-1.002.104.97
Change in Long Term Debt-0.15-0.15-0.15-0.15-0.14-0.33
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-0.15-0.15-0.15-0.15-0.14-0.33
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities1.71-4.64-7.12-11.27-8.09-5.32
Net Change in Cash-0.35-0.240.38-0.230.36-0.42
Free Cash Flow9.4312.5111.9513.9410.3413.85
Price to Free Cash Flow82.4482.6963.1262.4468.6377.22

Revenue breakdown

Real Estate Investment Trusts2024: 99.01M 2025: 99.19M
United States2024: 99.01M 2025: 99.19M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.20%0.3M12.7M126.62K
2026-10-152.52%0.3M12.7M118.24K
2026-09-303.00%0.4M12.7M113.66K
2026-09-153.41%0.4M12.7M164.06K
2026-08-313.18%0.4M12.7M166.82K
2026-08-142.90%0.4M12.7M162.33K
2026-07-313.03%0.4M12.7M155.27K
2026-07-152.96%0.4M12.7M152.42K
2026-06-301.85%0.2M12.7M136.24K
2026-06-153.95%0.5M12.7M75.30K
2026-05-293.35%0.4M12.7M64.00K
2026-05-153.22%0.4M12.7M63.20K
2026-04-302.98%0.4M12.7M65.41K
2026-04-152.37%0.3M12.7M65.58K
2026-03-312.30%0.3M12.7M66.31K
2026-03-132.37%0.3M12.7M69.25K
2026-02-272.19%0.3M12.7M73.77K
2026-02-132.11%0.3M12.7M85.32K
2026-01-302.34%0.3M12.7M86.57K
2026-01-152.29%0.3M12.7M88.95K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call22.5014.0018.500.004.5510.000.000.969-0.0380.004
call25.0011.5016.000.003.9170.000.000.963-0.0370.005
call30.006.5011.008.892.7391.000.000.945-0.0330.007
call35.001.506.003.301.7031.000.000.670-0.3380.022
call40.000.050.500.420.46742.000.000.389-0.1000.023
call45.000.001.300.050.9710.001.000.170-0.0810.015
call50.000.004.900.000.8450.000.000.027-0.0170.004
call55.000.004.900.001.7000.000.000.112-0.1070.011
call60.000.004.900.001.9790.000.000.100-0.1150.011
put22.500.000.200.003.7320.000.00-0.116-0.2360.012
put25.000.004.900.005.3520.000.00-0.176-0.4610.016
put30.000.000.150.011.2611.000.00-0.091-0.0690.010
put35.000.004.900.502.8161200.00-0.334-0.3340.022
put40.000.054.900.001.6430.000.00-0.604-0.1050.023
put45.004.008.800.001.9070.000.00-0.817-0.0890.016
put50.009.0013.900.002.3670.000.00-0.867-0.1000.013
put55.0014.0018.900.002.8650.000.00-0.878-0.1160.012
put60.0019.1024.000.003.2320.000.00-0.898-0.1160.011

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-278-KCurrent report2026-10-27SEC
2026-08-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-278-KCurrent report2026-07-27SEC
2026-07-08SCHEDULE 13G/ASEC
2026-06-118-KCurrent report2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-114Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-054Statement of changes in beneficial ownership of securities2026-06-05SEC
2026-05-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-29SCHEDULE 13GSEC
2026-04-28DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-28DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-10SEC
2026-04-28ARSAnnual report to security holders. 2025-12-31SEC
2026-04-278-KCurrent report2026-04-27SEC
2026-04-248-KCurrent report2026-04-21SEC
2026-03-27SCHEDULE 13G/ASEC
2026-02-258-KCurrent report2026-02-25SEC
2026-02-2510-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-01-21SCHEDULE 13G/ASEC
2025-11-0710-QQuarterly report pursuant to Section 13 or 15(d)2025-09-30SEC
2025-10-304Statement of changes in beneficial ownership of securities2025-10-29SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
BlackRock, Inc.10.75%
VANGUARD PORTFOLIO MANAGEMENT LLC6.09%
VANGUARD CAPITAL MANAGEMENT LLC4.04%
STATE STREET CORP2.72%
GEODE CAPITAL MANAGEMENT, LLC2.65%
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.2.55%
JANE STREET GROUP, LLC1.93%
TWO SIGMA INVESTMENTS, LP1.65%
Qube Research & Technologies Ltd1.49%
CITADEL ADVISORS LLC1.45%

Funds

Fund% owned
VANGUARD REAL ESTATE INDEX FUND3.52%
VANGUARD TOTAL STOCK MARKET INDEX FUND2.88%
Global X SuperDividend U.S. ETF2.52%
iShares Russell 2000 ETF2.48%
Fidelity Small Cap Index Fund1.08%
VANGUARD EXTENDED MARKET INDEX FUND1.07%
ProShares Russell 2000 Dividend Growers ETF1.04%
iShares Russell 2000 Growth ETF0.80%
VANGUARD STRATEGIC EQUITY FUND0.68%
Schwab Global Real Estate Fund0.62%

OakChart. UHT. Cached 15 minutes.

Some panels did not load: insider.